Annual Accounts Payable
$17.27 M
+$11.23 M+185.76%
December 31, 2024
Summary
- As of March 10, 2025, PTCT annual accounts payable is $17.27 million, with the most recent change of +$11.23 million (+185.76%) on December 31, 2024.
- During the last 3 years, PTCT annual accounts payable has fallen by -$5.76 million (-25.00%).
- PTCT annual accounts payable is now -36.65% below its all-time high of $27.27 million, reached on December 31, 2022.
Performance
PTCT Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Accounts Payable
$17.27 M
+$3.98 M+29.96%
December 31, 2024
Summary
- As of March 10, 2025, PTCT quarterly accounts payable is $17.27 million, with the most recent change of +$3.98 million (+29.96%) on December 31, 2024.
- Over the past year, PTCT quarterly accounts payable has stayed the same.
- PTCT quarterly accounts payable is now -37.09% below its all-time high of $27.46 million, reached on March 31, 2024.
Performance
PTCT Quarterly Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Accounts Payable Formula
Accounts Payable = Beginning Accounts Payable + Purchases on Credit − Payments to Suppliers
PTCT Accounts Payable Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +185.8% | 0.0% |
| 3 y3 years | -25.0% | -9.8% |
| 5 y5 years | +67.3% | -9.8% |
PTCT Accounts Payable Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -36.6% | +185.8% | -37.1% | +185.8% |
| 5 y | 5-year | -36.6% | +185.8% | -37.1% | +185.8% |
| alltime | all time | -36.6% | +2679.0% | -37.1% | +6314.4% |
PTC Therapeutics Accounts Payable History
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2024 | $17.27 M(+185.8%) | $17.27 M(+30.0%) |
| Sep 2024 | - | $13.29 M(-45.3%) |
| Jun 2024 | - | $24.28 M(-11.6%) |
| Mar 2024 | - | $27.46 M(+354.2%) |
| Dec 2023 | $6.04 M(-77.8%) | $6.04 M(-68.4%) |
| Sep 2023 | - | $19.15 M(-25.6%) |
| Jun 2023 | - | $25.74 M(-2.2%) |
| Mar 2023 | - | $26.31 M(-3.5%) |
| Dec 2022 | $27.27 M(+18.4%) | $27.27 M(+30.7%) |
| Sep 2022 | - | $20.86 M(-8.8%) |
| Jun 2022 | - | $22.88 M(+24.6%) |
| Mar 2022 | - | $18.36 M(-20.3%) |
| Dec 2021 | $23.03 M(+23.4%) | $23.03 M(+7.3%) |
| Sep 2021 | - | $21.46 M(+3.1%) |
| Jun 2021 | - | $20.82 M(+8.9%) |
| Mar 2021 | - | $19.11 M(+2.4%) |
| Dec 2020 | $18.66 M(+80.8%) | $18.66 M(+19.2%) |
| Sep 2020 | - | $15.66 M(+1.3%) |
| Jun 2020 | - | $15.46 M(-3.8%) |
| Mar 2020 | - | $16.07 M(+55.7%) |
| Dec 2019 | $10.32 M(+72.0%) | $10.32 M(+15.2%) |
| Sep 2019 | - | $8.96 M(-12.3%) |
| Jun 2019 | - | $10.22 M(+4.4%) |
| Mar 2019 | - | $9.79 M(+63.1%) |
| Dec 2018 | $6.00 M | $6.00 M(-8.2%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2018 | - | $6.54 M(+49.8%) |
| Jun 2018 | - | $4.36 M(+40.6%) |
| Mar 2018 | - | $3.10 M(-79.7%) |
| Dec 2017 | $15.28 M(+142.6%) | $15.28 M(+155.0%) |
| Sep 2017 | - | $5.99 M(-1.1%) |
| Jun 2017 | - | $6.06 M(+69.4%) |
| Mar 2017 | - | $3.58 M(-43.2%) |
| Dec 2016 | $6.30 M(+9.0%) | $6.30 M(-67.3%) |
| Sep 2016 | - | $19.24 M(+14.5%) |
| Jun 2016 | - | $16.80 M(+4.8%) |
| Mar 2016 | - | $16.02 M(+177.3%) |
| Dec 2015 | $5.78 M(+40.0%) | $5.78 M(-33.7%) |
| Sep 2015 | - | $8.71 M(+155.9%) |
| Jun 2015 | - | $3.41 M(+8.5%) |
| Mar 2015 | - | $3.14 M(-24.0%) |
| Dec 2014 | $4.13 M(+267.3%) | $4.13 M(+696.9%) |
| Sep 2014 | - | $518.00 K(-15.5%) |
| Jun 2014 | - | $613.00 K(+58.4%) |
| Mar 2014 | - | $387.00 K(-65.6%) |
| Dec 2013 | $1.12 M(+80.8%) | $1.12 M(+10.5%) |
| Sep 2013 | - | $1.02 M(+139.1%) |
| Jun 2013 | - | $425.40 K(+58.0%) |
| Mar 2013 | - | $269.30 K(-56.7%) |
| Dec 2012 | $621.60 K(-66.9%) | $621.60 K |
| Dec 2011 | $1.88 M | - |
FAQ
- What is PTC Therapeutics annual accounts payable?
- What is the all time high annual accounts payable for PTC Therapeutics?
- What is PTC Therapeutics annual accounts payable year-on-year change?
- What is PTC Therapeutics quarterly accounts payable?
- What is the all time high quarterly accounts payable for PTC Therapeutics?
- What is PTC Therapeutics quarterly accounts payable year-on-year change?
What is PTC Therapeutics annual accounts payable?
The current annual accounts payable of PTCT is $17.27 M
What is the all time high annual accounts payable for PTC Therapeutics?
PTC Therapeutics all-time high annual accounts payable is $27.27 M
What is PTC Therapeutics annual accounts payable year-on-year change?
Over the past year, PTCT annual accounts payable has changed by +$11.23 M (+185.76%)
What is PTC Therapeutics quarterly accounts payable?
The current quarterly accounts payable of PTCT is $17.27 M
What is the all time high quarterly accounts payable for PTC Therapeutics?
PTC Therapeutics all-time high quarterly accounts payable is $27.46 M
What is PTC Therapeutics quarterly accounts payable year-on-year change?
Over the past year, PTCT quarterly accounts payable has changed by $0.00 (0.00%)